Open original FDA record ↗Recall record
- FDA identifier
- Z-1183-2021
- Company in FDA record
- OraSure Technologies, Inc.
- FDA record creation date
- Mar 5, 2021
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class III
Reason stated in the source
Incorrect lot of Substrate Reagent (TMB) may be included in the kit. The original kit box labeling and the specification sheet listed the Substrate Reagent (TMB) lot 6676239, but contained Substrate Reagent (TMB) lot 6679623, should not affect performance.
Source facts
- Action
- Orasure issued Advisory Letters issued on 2/05/21 via Certified Mail receipt. Letter states reason for recall, health risk and action to take: OraSure Technologies, Inc. has generated a new Specification Sheet for the Methamphetamine Kit with the alternate Substrate Reagent Lot 6679623 included with this advisory letter. Retain testing done using the alternate Substrate Reagent revealed no impact to the kit's performance. If you have any questions regarding this issue please contact out Technical Services Department at technicalserviceQcorasure.coin and they can assist you
- Initiated
- 2021-02-05
- Root cause
- Packaging process control
- Terminated
- 2023-03-30
- Distribution
- US Nationwide distribution in the states of KS, NJ, OH, VA.
- Recall number
- Z-1183-2021
- Recall status
- Terminated
- CDRH record ID
- 185840
- FDA record created
- 2021-03-05
- Recall event number
- 87340